Miller Care Group Layout

specializing in addiction recovery

CALL TODAY

8355 Rockville Rd Suite 120 Indianapolis, IN 46234

2215 S. Curry Pike Bloomington, IN 47403

317.429.0061

MILLERCAREGROUP.COM

Miller Care Group Wound Care Specialists & In-Home Patient Treatment The Miller Care Group is dedicated to, providing the highest quality, most cost-effective wound care and related services to our patients. Regardless of extraneous factors, such as age, social or economic status, we strive to provide the highest quality of care to all. "Above and Beyond is always our norm, never the exception" Dr. Michael Miller DO FACAS, FAPWCA, WCC Wound Care Miller Care Group prides themselves on providing quality care and, specializes in treating severe, non-healing wounds. Our Research At the Miller Care Group, we strive to ensure the most aggressive, least expensive treatment options for our wound care patients. Full Medical Treatment Miller Care Group treats a variety of chronic non-healing wounds various long-term care settings, and in patient's homes. Health and Nutrition Nutrition is an integral part of the wound healing process. When the body has an injury, nutritional requirements will change.

"Above and Beyond is always our norm, never the exception" - Dr. Michael Miller DO FACAS, FAPWCA, WCC

MEDICAL PROVIDERS Miller Care Group - Indianapolis, IN

Dr. Michael Miller is the CEO and Medical Director of Miller Care Group. Dr. Miller is a board-certified general surgeon who has been practicing chronic wound management since 1997. He has traveled all over the world and provided wound care and related education through lectures, peer-reviewed articles, and book chapters as well as volunteering annually in Honduras. He became certified in addiction treatment in 2015 and also provides advanced pain management. In 2010, he was honored by being named the Physician of the Year by the American Osteopathic Foundation. He is an Assistant Professor at Marion University College of Osteopathic Medicine where he lectures and mentors medical students.

Dr. Michael Miller DO FACOS, FAPWCA, WCC AOF Physician of the Year MEDICAL DIRECTOR

Paul started his journey by getting his BA at Wabash College. He continued his studies by attaining his MS at Purdue University, and his PhD at Indiana University. He got his HSPP from the Indiana State Psychology Board in 1989. Paul has worked in correctional facilities, school systems, community mental health systems and private practice. He has evaluated and treated patients of all age groups, backgrounds, and clinical diagnoses. He now works as a Therapist here at Miller Care Group working mostly with people on house calls.

Paul Smith PhD LICENSED PSYCHOLOGIST

Peg began her enthusiasm for home visits while obtaining an undergraduate degree in social work at Union College in Southeastern Kentucky. She received her Master’s degree in social work from the University of Kentucky. Peg has worked in Community Mental Health centers, private practice, and a Psychiatric hospital. In addition to being a psychotherapist, she has recently received the title of Health Coach from the Institute for Integrative. This gives her the opportunity to identify possible nutritional deficiencies in relation to chronic pain and diseases. Peg is currently the Program Manager for the Miller Care Group Mental Health service, as well as a therapist.

Peg Black MSW, LCSW THERAPIST, PROGRAM MANAGER

We are dedicated to initiating the undertreated or untreated

Dr. Hardin received a Bachelor’s degree in comparative zoology in 1980 from Eastern Illinois University. His medical degree is from University of Illinois, with an internship in Internal Medicine. Dr. Hardin was introduced to wound care during his residency in Physical Medicine and Rehabilitation. He obtained his “Suboxone Waver” in order to do his part to ameliorate the opiate crisis. He continues to maintain a practice in Inpatient Rehabilitation at Lafayette Regional Rehabilitation Hospital and Carmel Health and Rehabilitation. Dr. Hardin is currently a Physiatrist, Wound Specialist, and Addictionology Specialist for Miller Care group. His role in Miller Care Group emphasizes his 30+ years of experience in wound care. Marsha studied at Purdue University and got her Bachelors and MS in Psychology and Neurological Disorders. She then attained her PhD in Psychology and Community Counseling from Western Michigan University in 1997. She has had experience working with individuals, families, and community organizations in therapy regarding various subjects like Substance Abuse treatment, Conflict Resolution, Grief Management, Family Dynamics, and Organizational Development. She now works as a Therapist doing house calls here at Miller Care Group. Barbara lives in Indianapolis and is a graduate of Indiana University with a Bachelors of Science in Public Health. She is also a graduate of Indiana Wesleyan University with a Masters in Community Mental Health. Barbara has worked in environmental regulation as well as addiction recovery for many years. Most recently, Barbara has worked in the community providing mental health and addiction recovery counseling for families in the Department of Child Services system. She is licensed and certified in addiction recovery counseling, and is pending for a license in mental health counseling.

David Hardin MD PHYSICIAN

Marsha Goin PhD, CADCII THERAPIST

Barbara Humphrey MA, LCAC, CADACII THERAPIST

Jody has studied at multiple institutions like Ivy Tech and Indiana University, only to continue her education later at Ball State University, graduating from there in 2005. Jody has worked in primary care of the family, with more than 30 years of work with direct patient care in diverse settings. She has had over 11 years of experience in family practice, and has mentored new Nurse Practitioner students and employees. She now is a Nurse Practitioner for Miller Care Group at the Bloomington location, specializing in pain management.

Jody Root MSN, FNP-BC NURSE PRACTITIONER

highest quality care for those with medical, behavioral, and social issues

HELPING TO PUT THE PIECES TOGETHER

317-429-0061 It’s Never Too Late...Call For Help NOW!

www.millercaregroup.com

Indy Transitions Addiction Recovery is one of the only non-hospital affiliated comprehensive out- patient treatment programs. We offer a team of Addiction Recovery specialists including nurse case managers, certified addiction providers (including physicians and other clinicians), and mental and behavioral health providers to treat all aspects of the substance abuse spectrum.

we do not trade one addiction for another

Appointments After you come in and fill out paperwork we will have to verify your Insurance. We accept most major insurances including the Healthy Indiana Plans. Depending on the patient’s insurance plan, we see them either twice a month or monthly, alternating between doctor visits and therapy visits, in order to treat both the physical and mental aspects of recovery.

Treatment We are a weaning program, that offers a comprehensive out-patient treatment program including stabilization on buprenorphine/naloxone medication, individualized titration plan, and long term recovery plan including continued mental health counseling and Naltrexone to maintain sobriety. Individual Plans No one situation is the same as the other, so they should not be treated in the exact same way. Our care is not cookie cutter because each patient is unique, so we create an individualized plan encompassing all aspects of each patients specific addiction recovery issues. Our motto is we do not trade one addiction for another. We are experts in dealing with mental illness related addiction issues as well.

What We Do The Indy Pain program was created to meet the needs of patients with acute and chronic pain issues. We make the diagnoses and can identify the right treatment by identifying all the specific causes of pain in each individual. We then can create a tailored treatment program using a multifocal approach. We integrate all the pertinent treatment considerations into a comprehensive treatment program for each patient. We initiate medication regimens that help treat all the associated issues that are created by and related to your pain such as insomnia, anxiety, depression, etc.

Therapy Sessions We also integrate mental health counseling into our treatment program since pain plays a significant part in ones’ mental health. We have therapists that are available in the office or that can make in home visits (if covered by insurance) to fit in best with your needs. Doing Your Part Compliance with our treatment recommendations is an integral part of pain management. We recognize the significant political and societal concerns regarding controlled substance prescribing and adhere strictly to all the current guidelines and mandates for ethical yet medico-legally appropriate care.

Examples of Our Comprehensive Treatment Include:

• Medication • Physical Therapy • Occupational Therapy • TENS units/Braces • Injections • Chiropractors • Referrals as necessary (Invasive pain management groups, ortho, etc.)

8355 ROCKVILLE ROAD SUITE 120 • INDIANAPOLIS, IN 46234 317.429.0061 CONTACT US TODAY

MILLER CARE GROUP PRIDES THEMSELVES ON PROVIDING QUALITY CARE AND, SPECIALIZES IN TREATING SEVERE, NON-HEALING WOUNDS.

SAMHSA PUBLISHES BEST PRACTICES ON MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER Best Practices

Treatment Improvement Protocol 63, “Medications for Opioid Use Disorder,”

reviews the use of methadone, naltrexone, and

buprenorphine, the three FDA-approved medications to treat opioid use disorders.

Data indicate that OUD-treating medications are both cost effective and cost beneficial

The Substance Abuse and Mental Health Services Administration has published new guidance to help health care professionals better understand medications that can be used to treat Americans with opioid use disorder (OUD). Treatment Improvement Protocol (TIP) 63, “Medications for Opioid Use Disorder,” reviews the use of methadone, naltrexone, and buprenorphine, the three FDA-approved medications to treat opioid use disorders. TIP 63 provides guidance for health care professionals and addiction treatment providers on how to appropriately prescribe these medications and effectively support patients using these medications for OUD treatment. “We know that people can and do recover from opioid use disorders when they receive appropriate treatment, and medication-assisted treatment’s success in treating opioid use disorders is well documented,” said Dr. Elinore F. McCance-Katz, assistant secretary for Mental Health and Substance Use. “TIP 63 emphasizes that increasing access to medications to treat opioid use disorder will help more people recover, enabling them to improve their health, living full and productive lives.” TIP 63 is part of SAMHSA’s larger response to the opioid crisis. More access to treatment with OUD medications is critical to closing the gap between treatment need and treatment availability and an important public health strategy. Data indicate that OUD-treating medications are both cost effective and cost beneficial.

Addiction There is a way out

2215 S. Curry Pike Bloomington, IN 47403 317-429-0061 www.millercaregroup.com

someone dies from a prescription drug overdose Don’t let one BAD choice be your LAST choice!

Are you missing 18%* of your Patients’ Positive Opioid Test Results? You may be without High Sensitivity Definitive Testing.

miller care group 317-429-0061 8355 Rockville Rd, Suite 120 Indianapis, IN 46234

not just a bad habit It’s NOT JUSTA BAD HABIT

Recent research and dialogue in the political sphere have brought long-simmering questions about addiction to the forefront: Is addiction truly a disease? Do addicts deserve to be treated like people who have a Recent res arch and ialogue in the political spher have brought long-sim ering questions about ad iction to the fore: Is addiction truly a disease? Do addicts deserve to b tr ated like people who hav a dise s that’s outside their control? disease that’s outside their control? While most researchers agree with the so-called disease model of addiction, stereotypes and cultural bias continue to stigmatize those with addiction because they made an initial choice to consume substances. However, Columbia University researchers point out that “choice does not determine whether 34 While most res archers agre with the so-called isease model of ad iction, ster otypes and cultural bias continue to stigmatize those with ad iction because they made an initial choice to consume substances. However, Columbia University res archers point out that “choice does not det rmine whether

something is a disease. Heart disease, diabetes and some forms of cancer involve personal choices like diet, exercise, sun exposure, etc. A disease is what happens in the body as a result of those choices.” Experts say that applying the distinction of choice to addiction creates biases that justify inadequate treatment. It begs the question New Jersey Gov. Chris Christie asked during a 2015 town hall meeting in New Hampshire. When Christie’s mother was diagnosed something is a disease. Heart disease, diabet s and some forms of cancer involve personal choices like diet, exercise, sun exposure, etc. A disease is what hap ens in the body as a result of those choices.” Experts ay that ap lying the distinction of choice to ad iction creates biases that justify inadequate treatment. It begs the question New Jersey Gov. Chris Christie asked uring a 2015 town hall me ting in New Hampshire. When Christie’s mother was diagnosed with lung cancer at 71 as a result of addiction to tobacco, he noted that with lung cancer at 71 as a result of ad iction to tobacco, he noted that

no one suggested that she should not be treated because she was “getting what she deserved,” he said. “Yet somehow, if it’s heroin or cocaine or alcohol, we say, ‘Ahh, they decided that, they’re getting what they deserve,’” Christie remarked. HOW ADDICTION WORKS After satisfying basic human needs like food, water, sleep and safety, people feel pleasure. That pleasure is brought by chemical releases in the brain. This is according to Columbia researchers, who note that the disease of addiction causes the brain to release high levels of those pleasure chemicals. Over time, brain functions of reward, motivation and memory are altered. After these brain systems are compromised, those with addiction can experience intense cravings for substance use, even in the face of harmful consequences. These changes can stay in the brain long after substance use desists. The changes may leave those struggling with addiction to be vulnerable to “physical and environmental cues they associate with substance use, also known as triggers, which can increase their risk of relapse,” write Columbia researchers.

not just a bad habit treatment and continued monitoring and support or recovery.

THE COLUMBIA RESEARCHERS DO HAVE SOME GOOD NEWS: Even the most severe, chronic form of the disorder can be manageable and reversible, usually with long term

35

MILLER CARE GROUP

• INDY WOUND CARE • INDY LYMPHEDEMA • INDY PSYCH • INDY TRANSITIONS • LIMB PRESERVATION

(317)429-0061 www.millercaregroup.com

Why Don’t They Just Quit?

Hope for families struggling with addiction. www.millercaregroup.com

Sign of the times Experts say the newly approved implant also provides a big boost to the concept of medication-assisted treatment (MAT) in general. For years, the idea that someone could achieve recovery through the use of drugs like methadone and buprenorphine was rejected by many professionals in the eld who saw complete abstinence as the only true sobriety. Many still hold that belief, but attitudes appear to be changing. Top government oŽcials say they want to increase the amount of MAT taking place at the country’s treatment centers. Several states as well as the federal government have enacted laws making it easier for physicians to prescribe medications like buprenorphine, but they say too few patients receive the medication they need. National Institute on Drug Abuse, in a statement. “is product will expand the treatment alternatives available to people suering from an opioid use disorder.” ] [ "Opioid abuse and addiction have taken a devastating toll on American families.” - Dr. Robert M. Cali, FDA Commissioner “Scientic evidence suggests that maintenance treatment with these medications in the context of behavioral treatment and recovery support are more eective in the treatment of opioid use disorder than short-term detoxication programs aimed at abstinence,” said Dr. Nora Volkow, director of the

M

edication-assisted treatment is growing in popularity and acceptance among addiction recovery professionals. And now it’s taken a revolutionary step forward that could oer renewed hope to thousands of people struggling with an addiction to opioids. is summer, the U.S. Food and Drug Administration approved a new buprenorphine implant to treat opioid dependence. Buprenorphine had previously been available only as a pill or a dissolvable lm placed under the tongue. But the new implant, known as Probuphine, can administer a six-month dose of the drug to keep those dependent on opioids from using by reducing cravings and withdrawal symptoms. "Opioid abuse and addiction have taken a devastating toll on American families,” FDA Commissioner Dr. Robert M. Cali said in a statement. “We must do everything we can to make new, innovative treatment options available that can help patients regain control over their lives.” e implant comes in the form of four one-inch rods that are placed under the skin on the upper arm.e implant must be administered surgically and comes with the possibility of certain side eects, but experts say it could be more convenient and more eective for patients.ey say by eliminating the need to take pills, ll prescriptions and generally manage their medication, it makes it easier for people to focus on the other areas of their recovery while making it less likely someone will lapse in their treatment plan.

36

Brought toyou by:

Although the implant is certainly a new alternative, it has yet to show any increased success in keeping people from relapsing compared to the pill or lm tablet. In a study of the implant’s eectiveness, they found that 63 percent of people given the implant were free of illicit drugs at six months, compared to 64 percent of people who took buprenorphine by pill. Still, those rates are much higher than the success rates of people who follow abstinence-only treatment plans. And oŽcials hope the new implant will lead more people to get MAT, increasing the number of successful recoveries across the country.

37

miller care group 8355 Rockville Road Suite 120 Indianapolis, IN 46234 317-429-0061 www.millercaregroup.com

Believe you can and you’re halfway there.

317.429.0061

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32

Powered by